ArticleCancer research and treatment2021

Use of Gemcitabine plus Carboplatin is Associated with Poor Outcomes in Urothelial Carcinoma Patients with Chronic Kidney Disease Stage 4-5.

Hyung-Don Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.